A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Novo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

CryoEM Confirms a First-in-Class Allosteric Binding Mode, Validating MolecuLernTM AI-Driven Discovery LEHI, Utah, March 14, 2025 /PRNewswir ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the globa ...

The Taoiseach Micheal Martin’s White House encounter with Donald Trump was controversial even before it was announced. Before any invitation had been extended, Sinn Fein said they were going ...

Corporate America is worried about their executives, so companies pay millions for CEO security. But rank-and-file workers in ...

These companies, also known as the "Magnificent Seven," led the stock market to new heights in 2023 and 2024, but have ...